Primary biliary cirrhosis: how should we evaluate new treatments?
- 1 May 1994
- journal article
- Published by Elsevier in The Lancet
- Vol. 343 (8909) , 1305-1306
- https://doi.org/10.1016/s0140-6736(94)92461-9
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ursodiol for the Long-Term Treatment of Primary Biliary CirrhosisNew England Journal of Medicine, 1994
- Ursodeoxycholic acid in the treatment of primary biliary cirrhosisGastroenterology, 1994
- Cyclosporin a treatment in primary biliary cirrhosis: Results of a long-term placebo controlled trialGastroenterology, 1993
- Treatment of primary biliary cirrhosis with low-dose weekly methotrexateGastroenterology, 1991
- Prognosis in primary biliary cirrhosis: Model for decision makingHepatology, 1989
- TYPE III PROCOLLAGEN PEPTIDE: A MARKER OF DISEASE ACTIVITY AND PROGNOSIS IN PRIMARY BILIARY CIRRHOSISThe Lancet, 1988
- Clinical and statistical analyses of new and evolving therapies for primary biliary cirrhosisHepatology, 1988
- A controlled trial of colchicine in primary biliary cirrhosisJournal of Hepatology, 1987
- A Prospective Trial of Colchicine for Primary Biliary CirrhosisNew England Journal of Medicine, 1986
- The Prognostic Importance of Clinical and Histologic Features in Asymptomatic and Symptomatic Primary Biliary CirrhosisNew England Journal of Medicine, 1983